#Europe

2021-04-08

Coronavirus: Commission mobilises €123 million for research and innovation to combat the threat of variants

The Commission is mobilising €123 million from Horizon Europe, the new EU research and innovation programme, for urgent research into coronavirus variants. This first emergency funding under Horizon Europe adds to a range of EU-funded research and innovation actions to fight the coronavirus and contributes to the Commission's overall action to prevent, mitigate and respond to the impact of coronavirus variants, in line with the new European bio-defence preparedness plan HERA Incubator.

Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: “We continue to mobilise all means at our disposal to fight this pandemic and the challenges presented by coronavirus variants. We must use our combined strength to be prepared for the future, starting from the early detection of the variants to the organisation and coordination of clinical trials for new vaccines and treatments, while ensuring correct data collection and sharing at all stages.”

New calls for urgent research into coronavirus variants

The Commission launched new calls that complement earlier actions to develop treatments and vaccines by organising and conducting clinical trials to advance the development of promising therapeutics and vaccines against SARS-CoV-2/COVID-19. They will support the development of large scale, COVID-19 cohorts and networks beyond Europe's borders, forging links with European initiatives, as well as reinforce the infrastructures needed to share data, expertise, research resources and expert services among researchers and research organisations.

The projects funded are expected to:

• Establish new and/or build on existing large-scale, multi-centre and regional or multinational cohorts, including beyond Europe's borders, which should rapidly advance the knowledge on SARS-CoV-2 and its emerging variants.

• Further develop promising therapeutic or vaccine candidates against SARS-CoV-2/COVID-19, having already completed preclinical development in clinical studies.

• Support research infrastructures to speed up data sharing and deliver fast research support and expertise, to confront the coronavirus variants and to be ready for future epidemics.

The successful consortia are expected to collaborate with other relevant initiatives and projects at national, regional, and international level to maximise synergies and complementarity and avoid duplication of the research efforts.

These emergency calls will tackle the short to medium-term threat and simultaneously prepare for the future. They will contribute to building the European Health Emergency Preparedness and Response Authority (HERA), which will enable the EU to anticipate and better tackle future pandemics.

The calls will open for submissions on 13 April and the deadline for submission is 6 May 2021. The new solutions need to be available and affordable for all, in line with the principles of the Coronavirus Global Response.

Background

In February 2021, Commission President Ursula von der Leyen announced the start of a European bio-defence preparedness plan HERA Incubator aimed at preparing Europe for an increased threat of coronavirus variants. The HERA Incubator will bring together science, industry and public authorities, and leverage all available resources to enable Europe to respond to this challenge.

Since the beginning of the crisis, but also since much earlier, the Commission has been at the forefront of supporting research and innovation and coordinating European and global research efforts, including preparedness for pandemics. It has pledged €1.4 billion to the Coronavirus Global Response, of which €1 billion comes from Horizon 2020, the previous EU research and innovation programme.

The new special calls announced today under Horizon Europe, the successor of Horizon 2020, complement these earlier actions to fight the coronavirus: support for 18 projects with €48.2 million to develop diagnostics, treatments, vaccines and preparedness for epidemics; 8 projects with €117 million invested on the development of diagnostics and treatments through the Innovative Medicines Initiative; 24 projects with €133.4 million granted to addressing pressing needs and the socio-economic impact of the pandemic; and other measures to support innovative ideas through the European Innovation Council. The calls implemented action 3 of the ERAvsCorona Action Plan, a working document resulting from dialogues between the Commission services and national institutions.

“Production is a product”

From technical textiles and AI-driven robotics to the limitations of textile circularity: Professor Dr Thomas Gries looks back on more than two decades of development at ITA Aachen. In the interview, he explains why production technology remains a decisive success factor, discusses international collaborations and innovation ecosystems, and shares his views on the transformation of production landscapes and the challenges facing an increasingly regulated industry.

“We need to move away from the price trap and return to a value-driven mindset.”

With its new Textile Innovation Center, KARL MAYER is sending a strong signal for innovation, collaboration, and the future of textile applications. In this interview, Karl Josef Mayer discusses new opportunities in warp knitting, the processing of staple fibres, recycling, the changing role of machinery manufacturers, and why the textile industry must once again focus more strongly on the value of textiles. by Oliver Schmidt

“Innovation, resilience and international experience remain the great strengths of the Swiss textile machinery industry”

Geopolitical uncertainty, growing competitive pressure from China, new free trade agreements and the shift towards a circular economy are currently reshaping the global textile industry. In this interview, Cornelia Buchwalder discusses the current mood within the Swiss textile machinery sector, the industry’s distinctive innovative strength, new market opportunities in India and Asia, and the technological trends that could shape the upcoming trade fair cycle leading up to ITMA 2027.

EU ban on destroying unsold clothing and footwear now in force

The European Union's ban on the destruction of unsold clothing, clothing accessories and footwear has entered into force. Since July 19, 2026, large companies across the EU have been prohibited from destroying unsold textile products, while medium-sized companies will be required to comply with the same rules from 2030.

Commission clarifies rules on plastic bottles recycling

The European Commission today adopted new rules on recycling of single-use plastic beverage bottles made primarily of polyethylene terephthalate (PET bottles). These rules establish, for the first time, a methodology to calculate, verify and report chemically recycled content. This is part of the Commission’s December 2025 plastics package.

Circular economy offers the EU win-win on environment and economy

Stepping up a circular economy offers the European Union the potential for significant positive impacts on Europe’s environment and poses an untapped and strategic economic opportunity in terms of better access to materials and the creation of new businesses. Three new assessments on circularity, published today by the European Environment Agency (EEA), also stress the need to accelerate investment in circularity efforts to meet EU climate and environment policy targets.

Eastman Naia™ brings its inside-out denim vision to Kingpins New York

Following its debut at Kingpins Amsterdam, Eastman Naia™ brings the next chapter of its denim story to Kingpins New York, taking place July 22–23. At Booth Green 7, Naia™ presents its denim proposition built around three complementary design directions: Performance Denim, Fashion Denim and Authentic Denim.

Circ launches first denim collection with H&M featuring TENCEL™ | Circ® with REFIBRA™ technology

Circ today announced that the first men's denim collection featuring TENCEL™ | Circ® with REFIBRA™ technology is now available at H&M, marking the commercial delivery of this unique pilot project first announced in October 2025. Featuring two styles available across the UK, Scandinavia, Central Europe, Eastern Europe, South Europe, Turkey, North America, Mexico, Canada, and the Middle East, the launch brings TENCEL™ | Circ® with REFIBRA™ technology into H&M's standard men's denim assortment for the first time.